Palumbo Wealth Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Palumbo Wealth Management's ORGO Position: Q2 2026 in Review
Palumbo Wealth Management sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 57,849 shares — an estimated $137K sold.
Palumbo Wealth Management first reported a position in ORGO in Q4 2023 and held it in 6 quarters. The position peaked at $197K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Palumbo Wealth Management reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
- Palumbo Wealth Management sold 57,849 Organogenesis Holdings shares in Q2 2026, an estimated $137K.
- Palumbo Wealth Management first reported a position in Organogenesis Holdings in Q4 2023 and held it in 6 quarters.
- Palumbo Wealth Management's Organogenesis Holdings position peaked at $197K in Q4 2025.
- 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.